Biobizkaia
Research center
University of Texas Medical Branch at Galveston
Galveston, Estados UnidosPublications in collaboration with researchers from University of Texas Medical Branch at Galveston (23)
2024
-
Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial
eClinicalMedicine, Vol. 72
-
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry
Rheumatology (United Kingdom), Vol. 63, Núm. 3, pp. 772-779
-
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)
Seminars in Arthritis and Rheumatism, Vol. 65
2023
-
Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository
Arthritis and Rheumatology, Vol. 75, Núm. 8, pp. 1407-1414
-
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study
Laboratory investigation; a journal of technical methods and pathology, Vol. 103, Núm. 6, pp. 100147
-
Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial
eClinicalMedicine, Vol. 64
2022
-
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository
Arthritis Care and Research, Vol. 74, Núm. 2, pp. 324-335
-
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
Lupus, Vol. 31, Núm. 14, pp. 1770-1776
2021
-
Antiphospholipid antibody profile stability over time: Prospective results from the APS ACTION clinical database and repository
Journal of Rheumatology, Vol. 48, Núm. 4, pp. 541-547
-
Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository
Advances in Rheumatology, Vol. 61, Núm. 1
-
Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78
-
Global wealth disparities drive adherence to COVID-safe pathways in head and neck cancer surgery
BJS Open
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
-
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score
British Journal of Surgery, Vol. 19, Núm. 4
2020
-
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry
Lupus, Vol. 29, Núm. 11, pp. 1353-1363
2019
-
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository
Journal of Thrombosis and Haemostasis, Vol. 17, Núm. 12, pp. 2069-2080
-
Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study
BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 126, Núm. 5, pp. 656-661
-
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort
Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 3, pp. 464-468
-
The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis
Thrombosis Research, Vol. 175, pp. 32-36